1. China Stocks

  2. •

    Producer manufacturing

  3. •

    Miscellaneous manufacturing
Blue Sail Medical Co., Ltd. Class A

Blue Sail Medical Co., Ltd. Class A

SSZSE:002382
5.68
CNY
-0.12
(-2.07%)
-0.51EPS
5.12BMarket Cap
Oct 26Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.84
3.23
3.1
2.63
3.22
3.6
3.62
8.14
7.93
4.87
4.85
6.17
5.75
6.55
Basic EPS, GAAP
0.1
0.13
0.35
0.37
0.41
0.47
0.51
1.82
1.13
-0.37
-0.56
-0.44
-0.76
-0.59
Free Cash Flow per Basic Share
-0.34
0.16
0.44
0.13
-0.06
0.28
0.44
2.55
-0.33
-0.4
-0.83
-0.63
-0.1
- -
Dividend per Share
0.11
0.08
0.11
0.2
0.21
0.21
0.14
0.29
0.47
0.06
0.51
0.18
0.17
0.27
Book Value per Share
2.05
2.17
2.39
2.63
2.88
8.09
8.75
10.01
10.46
10.48
9.48
8.29
7.11
7.08
Tangible Book Value per Share
1.55
1.96
2.2
2.43
2.69
0.3
0.78
3.25
6.02
5.54
4.39
3.14
1.89
2.02
Basic Weighted Avg Shares
470
475
486
489
490
738
961
966
1,023
1,006
1,015
1,013
999
1,002
Sales/Revenue/Turnover
1,335
1,535
1,509
1,289
1,576
2,653
3,476
7,869
8,109
4,900
4,927
6,253
5,740
6,566
Operating Margin (%)
4.23
5.74
14.51
14.07
18.23
15.19
18.77
52
32.03
-10.75
-9.54
-2.19
-2.94
6.95
Depreciation Expense
41
58
45
45
52
135
186
214
332
489
525
526
573
- -
Net Income, GAAP
47
62
170
181
201
347
490
1,758
1,156
-372
-568
-446
-759
-589
Effective Tax Rate (%)
21.76
15.43
25.11
18.06
20.36
0.72
9.86
12.65
14.22
- -
- -
- -
- -
- -
Profit Margin (%)
3.52
4.02
11.28
14.05
12.75
13.07
14.11
22.35
14.25
-7.6
-11.54
-7.13
-13.22
-8.97
Working Capital
21
310
465
566
374
999
787
3,511
3,157
2,144
-139
2,380
-968
-454
LT Debt
153
- -
- -
- -
- -
2,436
1,944
3,404
2,928
2,842
1,826
2,667
626
666
Total Equity
984
1,046
1,184
1,300
1,428
7,800
8,463
9,817
10,536
10,552
9,548
10,067
9,461
9,513
Return on Invested Capital (%)
1.91
4.04
13.42
14.35
14.73
5.54
4.32
12.93
8.06
- -
- -
- -
- -
- -
Return on Capital (%)
4.42
5.93
14.02
14.67
14.43
6.35
4.77
13.94
8.56
- -
- -
- -
- -
- -
Return on Common Equity (%)
4.83
6.09
15.3
14.59
14.74
7.52
6.04
19.27
11.36
-3.53
-5.66
-4.98
-9.79
-7.66

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
4,544
4,040
2,406
LT Borrowings
617
655
648
LT Finance Leases
9
7
18
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,007
1,007
1,008
Market Capitalization
5,640
8,017
5,119

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5,506
5,080
4,529
Cash, Cash Equivalents & STI
2,635
2,278
1,479
Accounts Receivable, Net
1,084
1,245
1,545
Inventories
1,127
1,109
1,094
Total Current Liabilities
6,475
5,822
4,983
Payables & Accruals
- -
- -
- -
ST Debt
4,544
4,040
2,406
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
48.77%
-0.53%
-6.03%
Free Cash Flow
-56.28%
-18.63%
-85.07%
Net Income, GAAP
32.49%
-13.02%
70.32%
Sales/Revenue/Turnover
21.62%
-3.46%
-8.21%
Total Cash Common Dividend
88.97%
130.67%
-5.1%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,455
1,551
1,649
1,599
6,253
2025
1,528
1,303
- -
1,558
5,740
2026
1,625
2,081
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.1
-0.06
-0.06
-0.23
-0.44
2025
0.08
-0.21
- -
-0.47
-0.76
2026
- -
0.09
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.05
0.03
0.07
0.18
2025
0.02
0.04
- -
0.08
0.17
2026
0.01
0.13
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Shu Qiao Zhong
Full Time Employees
8,962
Sector
Producer manufacturing
Industry
Miscellaneous manufacturing
Address
48 Yinuo Road Zibo SD China 255400
IPO Date
Apr 6, 2010
Website
bluesail.cn
Similar Companies
Astral Limited (NSE:ASTRAL)
Supreme Industries Limited (NSE:SUPREMEIND)
V.S. Industry Bhd. (MYX:VS)
Izmir Firca Sanayi ve Ticaret AS (BIST:IZFAS)
Kuzey Boru A.S. (BIST:KBORU)
Isik Plastik Sanayi VE Dis Ticaret Pazarlama AS (BIST:ISKPL)
Business
Blue Sail Medical Co., Ltd. (002382.SZ) manufactures and sells medical devices and health protection products principally in China and internationally. The company operates four primary business units offering healthcare protective products including disposable medical gloves such as latex, nitrile, PVC, and TPE/CPE varieties; cardio and neurovascular interventional devices including cardiovascular stents like BioFreedom polymer- and carrier-free drug-coated stents and EXCEL biodegradable drug-eluting stents, heart valves, neuro intervention, and peripheral intervention products; minimally invasive surgery equipment including endoscopic staplers, ultrasonic scalpels, general surgical instruments, and innovative therapy instruments; and medical healthcare supplies including first-aid kits, medical first-aid bags, family disaster prevention emergency kits, epidemic prevention kits, reflective vests, masks, and medical dressings. Bluesail Medical was founded in 2002 and is headquartered in Zibo, Shandong Province, China, with over 70 subsidiaries across more than 20 countries including production sites in Germany, Singapore, Vietnam, and China, and R&D centers in Germany, Shanghai, Singapore, and the United States; its products serve over 130 countries competing with global leaders such as Abbott, Boston Scientific, and Medtronic. In recent developments, the company's cardiovascular and cerebrovascular business unit Blue Sail Biosensors completed a record RMB 1 billion Series A funding round in 2024 comprising RMB 900 million in January and an additional RMB 100 million in May with investors including Beijing New Aerotropolis to accelerate strategic expansion in high-end medical devices and establish a northern headquarters platform; its protective business narrowed losses significantly in early 2024 with a Q2 turnaround to profitability while cardiovascular sales grew 12% in H1 with improved gross margins.